Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Carol M. Guarnieri"'
Publikováno v:
Journal of Clinical Oncology. 8:2054-2061
Fluorouracil (5-FU) and cisplatin display marked therapeutic synergy in preclinical models and are effective in the treatment of a number of solid tumors when combined and administered intravenously (IV). Each drug has also been administered intraper
Autor:
Richard L. Schilsky, Mark J. Ratain, William R. Panje, Carol M. Guarnieri, Everett E. Vokes, Kyung E. Choi, Ralph R. Weichselbaum, D M Magid, S M Whaling
Publikováno v:
Cancer. 63:30-36
This study was designed to evaluate the safety, reliability, and patient acceptance of outpatient continuous intravenous infusion (CVI) chemotherapy. Twenty-two patients with locally advanced head and neck cancer received induction chemotherapy with
Autor:
Susan M. Whaling, Richard L. Schilsky, Alfred Guaspari, Mary Ann Liebner, Carol M. Guarnieri, Everett E. Vokes, Kyung E. Choi
Publikováno v:
Cancer. 63:1018-1021
As part of a clinical trial of cisplatin, 5-fluorouracil (5-FU), and leucovorin (LV) for treatment of patients with advanced head and neck cancer, patients received 100 mg of LV (d,l-5-formyltetrahydrofolate) orally every 4 hours for 5 days. On days
Autor:
Everett E. Vokes, Richard L. Schilsky, Carol M. Guarnieri, Ralph R. Weichselbaum, Susan M. Whaling, Alfred Guaspari, William R. Panje
Publikováno v:
Cancer. 63:1048-1053
Both cisplatin and leucovorin may increase the activity of 5-fluorouracil (5-FU) by increasing the intracellular concentration of reduced folates. Therefore, a Phase I study was conducted in patients with recurrent or metastatic head and neck cancer
Autor:
Richard L. Schilsky, Mary Ann Liebner, Elizabeth K. Senekjian, Nicholas J. Vogelzang, Mark J. Ratain, Carol M. Guarnieri, Kyung E. Choi, Dale Grimmer
Publikováno v:
Clinical Pharmacology and Therapeutics. 45:226-233
We sought to use a previously derived pharmacodynamic model for 72-hour etoposide infusions to adaptively control administration of this agent and to demonstrate that more predictable toxicity could be obtained with this dosing scheme. A randomized c
Autor:
Ralph R. Weichselbaum, William J. Moran, Everett E. Vokes, Carol M. Guarnieri, Richard L. Schilsky, Kyung E. Choi, William R. Panje
Publikováno v:
Journal of Clinical Oncology. 6:618-626
We added high-dose oral leucovorin to the combination of cisplatin and fluorouracil (5-FU) to assess the efficacy of this regimen in the treatment of patients with head and neck cancer. Cisplatin, 100 mg/m2, was followed by a 5-FU continuous infusion
Autor:
William R. Panje, Everett E. Vokes, Azhar Awan, Ralph R. Weichselbaum, Carol M. Guarnieri, William J. Moran, Richard L. Schilsky
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 98(4)
We tested the combination of hydroxyurea (HU), 5-fluorouracil (5-FU), and concomitant radiotherapy (XRT) in a group of patients with advanced or recurrent head and neck cancer. Both drugs are effective single agents, have shown synergistic activity i
Autor:
Susan M. Whaling, Carol M. Guarnieri, D M Magid, Richard L. Schilsky, Everett E. Vokes, William R. Panje, Ralph R. Weichselbaum
Publikováno v:
Selective cancer therapeutics. 5(3)
This study was designed to test whether previously untreated patients with head and neck cancer could effectively manage home continuous infusion chemotherapy, and to compare their acceptance and adjustment to home versus inpatient treatment. Twenty-